Nicholas J Gow Robert N Davidson Rob Ticehurst Andrew Burns Mark G Thomas
10.1371/journal.pntd.0003983
PLoS Negl Trop Dis
2015 Aug 25;9(8):e0003983.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26305562/
Antiprotozoal Agents / administration & dosage Coinfection / drug therapy Daunorubicin / administration & dosage Drug Resistance HIV Infections / drug therapy Leishmaniasis, Visceral / drug therapy
Antiprotozoal Agents / administration & dosage Coinfection / drug therapy Daunorubicin / administration & dosage Drug Resistance HIV Infections / drug therapy Leishmaniasis, Visceral / drug therapy Case Reports Anti-HIV Agents / administration & dosage HIV-1 / physiology Humans Leishmania donovani / physiology Male Middle Aged Treatment Failure Anti-HIV Agents Antiprotozoal Agents Daunorubicin
PMC4549335
26305562
Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis
2015